In 2010 Nat Turner and Zach Weinberg sold their startup Invite Media to Google for $81 million dollars. At that time they were absorbed into Google where they spent the last two years. Now the co-founding team is back at it again, and navigating through unchartered territory.
Their new startup is New York City based Flatiron Health. FlatIron Health hopes to streamline cancer screening for clinical trials. Currently biomarkers among other diagnostics, are used to identify cancer patients for clinical trials however the team told Business Insider they feel that the process could be improved upon and streamlined.
“It’s actually very complicated to find out if you’re eligible,” Turner told SAI. “It’s like 120 variables and there’s no way to know quickly. We hope to speed that up for physicians because clinical trials are huge for cancer. In general, treatments fail and trials are the way to go.”
After both 26-year-old founders had loved ones suffer through cancer they knew their next mission would somehow be related to cancer. They admittedly don’t have their exact product yet however they’ve been holding weekly brainstorming sessions and have a pilot going with some of the major hospitals.
FlatIron Health is a far cry from the ad technology and bid manager platform Turner and Weinberg created with Invite Media. That platform allowed advertisers to manage online campaigns across multiple platforms.
Weinberg and Turner are in a better financial position than most new medical startups. They’re attacking this startup with the vigor of anxious entrepreneurs and aren’t intimidated by the fact that neither founder has any kind of background in medicine, biology or cancer.
“Flatiron Health is either going to be a great success or a horrible failure,” says Turner. “Hopefully we’ll do well by doing good.”
Here are some other Xoogler spotlights at nibletz.com